메뉴 건너뛰기




Volumn 12, Issue 3, 2003, Pages 273-282

Diabetes and nephropathy

Author keywords

Diabetic nephropathy; Pathology; Pathophysiology; Treatment

Indexed keywords

ANTIHYPERTENSIVE THERAPY; BLOOD PRESSURE REGULATION; DIABETES MELLITUS; DIABETIC NEPHROPATHY; GENE LOCUS; GENETIC PREDISPOSITION; GLUCOSE BLOOD LEVEL; HUMAN; KIDNEY FAILURE; PRIORITY JOURNAL; RENIN ANGIOTENSIN ALDOSTERONE SYSTEM; REVIEW; RISK ASSESSMENT;

EID: 0037614775     PISSN: 10624821     EISSN: None     Source Type: Journal    
DOI: 10.1097/00041552-200305000-00008     Document Type: Review
Times cited : (136)

References (131)
  • 1
    • 0038257951 scopus 로고    scopus 로고
    • Bethesda, MD: The National Institutes of Health, National Institute of Diabetes and Digestive and Kidney Diseases. April 1999. 11th Annual Report
    • United States Renal Data System. 1999 Annual data report. Bethesda, MD: The National Institutes of Health, National Institute of Diabetes and Digestive and Kidney Diseases. April 1999. 11th Annual Report.
    • (1999) Annual Data Report
  • 2
    • 0036317169 scopus 로고    scopus 로고
    • The early natural history of nephropathy in type 1 diabetes: I. Study design and baseline characteristics of the study participants
    • Mauer M, Drummond K. The early natural history of nephropathy in type 1 diabetes: I. Study design and baseline characteristics of the study participants. Diabetes 2002; 51:1572-1579. This describes the clinical and laboratorial characteristics of a large group of young type 1 diabetic patients participating in a multicenter study of the early history of diabetic nephropathy.
    • (2002) Diabetes , vol.51 , pp. 1572-1579
    • Mauer, M.1    Drummond, K.2
  • 3
    • 0036316997 scopus 로고    scopus 로고
    • The early natural history of nephropathy in type 1 diabetes: II. Early renal structural changes in type 1 diabetes
    • Drummond K, Mauer M. The early natural history of nephropathy in type 1 diabetes: II. Early renal structural changes in type 1 diabetes. Diabetes 2002; 51:1580-1587. The authors describe the renal structural findings and structural-functional relationships of a large group of young type 1 diabetic patients participating in a multicenter study of the early history of diabetic nephropathy.
    • (2002) Diabetes , vol.51 , pp. 1580-1587
    • Drummond, K.1    Mauer, M.2
  • 4
    • 0036068369 scopus 로고    scopus 로고
    • Cellular basis of diabetic nephropathy: 1. Study design and renal structural-functional relationships in patients with long-standing type 1 diabetes
    • Caramori ML, Kim Y, Huang C, et al. Cellular basis of diabetic nephropathy: 1. Study design and renal structural-functional relationships in patients with long-standing type 1 diabetes. Diabetes 2002; 51:506-513. This describes the renal structural findings and structural-functional relationships of long-standing type 1 diabetic patients with a wide range of clinical findings.
    • (2002) Diabetes , vol.51 , pp. 506-513
    • Caramori, M.L.1    Kim, Y.2    Huang, C.3
  • 5
    • 0036789206 scopus 로고    scopus 로고
    • Podocyte number in normotensive type 1 diabetic patients with albuminuria
    • White KE, Bilous RW, Marshall SM, et al. Podocyte number in normotensive type 1 diabetic patients with albuminuria. Diabetes 2002; 51:3083-3089.
    • (2002) Diabetes , vol.51 , pp. 3083-3089
    • White, K.E.1    Bilous, R.W.2    Marshall, S.M.3
  • 6
    • 0031029379 scopus 로고    scopus 로고
    • Podocyte loss and progressive glomerular injury in type II diabetes
    • Pagtalunan ME, Miller PL, Jumping-Eagle S, et al. Podocyte loss and progressive glomerular injury in type II diabetes. J Clin invest 1997; 99:342-348.
    • (1997) J Clin Invest , vol.99 , pp. 342-348
    • Pagtalunan, M.E.1    Miller, P.L.2    Jumping-Eagle, S.3
  • 7
    • 0032710966 scopus 로고    scopus 로고
    • Podocyte number predicts long-term urinary albumin excretion in Pima Indians with Type II diabetes and microalbuminuria
    • Meyer TW, Bennett PH, Nelson RG, Podocyte number predicts long-term urinary albumin excretion in Pima Indians with Type II diabetes and microalbuminuria. Diabetologia 1999; 42:1341-1344.
    • (1999) Diabetologia , vol.42 , pp. 1341-1344
    • Meyer, T.W.1    Bennett, P.H.2    Nelson, R.G.3
  • 8
    • 0036098930 scopus 로고    scopus 로고
    • An increase in the cell component of the cortical interstitium antedates interstitial fibrosis in type 1 diabetic patients
    • Katz A, Caramori ML, Sisson-Ross S, et al. An increase in the cell component of the cortical interstitium antedates interstitial fibrosis in type 1 diabetic patients. Kidney Int 2002; 61:2058-2066. The authors evaluated in detail the interstitial composition of long-standing type 1 diabetic patients.
    • (2002) Kidney Int , vol.61 , pp. 2058-2066
    • Katz, A.1    Caramori, M.L.2    Sisson-Ross, S.3
  • 9
  • 10
    • 0036016901 scopus 로고    scopus 로고
    • Urinary albumin as an indicator of diabetic nephropathy lesions in Japanese type 2 diabetic patients
    • Moriya T, Moriya R, Yajima Y, et al. Urinary albumin as an indicator of diabetic nephropathy lesions in Japanese type 2 diabetic patients. Nephron 2002; 91:292-299.
    • (2002) Nephron , vol.91 , pp. 292-299
    • Moriya, T.1    Moriya, R.2    Yajima, Y.3
  • 11
    • 0033843758 scopus 로고    scopus 로고
    • Type 2 diabetic patients with nephropathy show structural-functional relationships that are similar to type 1 disease
    • White KE, Bilous RW. Type 2 diabetic patients with nephropathy show structural-functional relationships that are similar to type 1 disease. J Am Soc Nephrol 2000; 11:1667-1673.
    • (2000) J Am Soc Nephrol , vol.11 , pp. 1667-1673
    • White, K.E.1    Bilous, R.W.2
  • 12
    • 0036839440 scopus 로고    scopus 로고
    • Effects of cigarette smoking on glomerular structure and function in type 2 diabetic patients
    • Baggio B, Budakovic A, Vestra MD, et al. Effects of cigarette smoking on glomerular structure and function in type 2 diabetic patients. J Am Soc Nephrol 2002; 13:2730-2736.
    • (2002) J Am Soc Nephrol , vol.13 , pp. 2730-2736
    • Baggio, B.1    Budakovic, A.2    Vestra, M.D.3
  • 13
    • 0036176173 scopus 로고    scopus 로고
    • Cigarette smoking predicts faster progression of type 2 established diabetic nephropathy despite ACE inhibition
    • Chuahirun T, Wesson DE. Cigarette smoking predicts faster progression of type 2 established diabetic nephropathy despite ACE inhibition. Am J Kidney Dis 2002; 39:376-382.
    • (2002) Am J Kidney Dis , vol.39 , pp. 376-382
    • Chuahirun, T.1    Wesson, D.E.2
  • 14
    • 0036194517 scopus 로고    scopus 로고
    • Different patterns of renal damage in type 2 diabetes mellitus: A multicentric study on 393 biopsies
    • Mazzucco G, Bertani T, Fortunato M, et al. Different patterns of renal damage in type 2 diabetes mellitus: a multicentric study on 393 biopsies. Am J Kidney Dis 2002; 39:713-720.
    • (2002) Am J Kidney Dis , vol.39 , pp. 713-720
    • Mazzucco, G.1    Bertani, T.2    Fortunato, M.3
  • 15
    • 0026591207 scopus 로고
    • An electron microscopic study of glomeruli in Japanese patients with non-insulin dependent diabetes mellitus
    • Hayashi H, Karasawa R, Inn H, et al. An electron microscopic study of glomeruli in Japanese patients with non-insulin dependent diabetes mellitus. Kidney Int 1992; 41:749-757.
    • (1992) Kidney Int , vol.41 , pp. 749-757
    • Hayashi, H.1    Karasawa, R.2    Inn, H.3
  • 16
    • 0036190236 scopus 로고    scopus 로고
    • Kidney function and glomerulopathy over 8 years in young patients with Type I (insulin-dependent) diabetes mellitus and microalbuminuria
    • Bangstad HJ, Osterby R, Rudberg S, et al. Kidney function and glomerulopathy over 8 years in young patients with Type I (insulin-dependent) diabetes mellitus and microalbuminuria. Diabetologia 2002; 45:253-261. The article reports on structural-functional relationships of microalbuminuric type 1 diabetic patients undergoing sequential kidney biopsies.
    • (2002) Diabetologia , vol.45 , pp. 253-261
    • Bangstad, H.J.1    Osterby, R.2    Rudberg, S.3
  • 17
    • 0035988186 scopus 로고    scopus 로고
    • Structural changes in renal arterioles in Type I diabetic patients
    • Osterby R, Hartmann A, Bangstad HJ. Structural changes in renal arterioles in Type I diabetic patients. Diabetologia 2002; 45:542-549. This reports on arteriolar structure in sequential kidney biopsies from microalbuminuric type 1 diabetic patients.
    • (2002) Diabetologia , vol.45 , pp. 542-549
    • Osterby, R.1    Hartmann, A.2    Bangstad, H.J.3
  • 18
    • 0037093012 scopus 로고    scopus 로고
    • Effect of intensive therapy on the microvascular complications of type 1 diabetes mellitus
    • The Writing Team for the Diabetes Control and Complications Trial/Epidemiology of Diabetes Interventions and Complications Research Group. Effect of intensive therapy on the microvascular complications of type 1 diabetes mellitus. JAMA 2002; 287:2563-2569. This paper summarizes the findings of the DCCT, and the subsequent observational follow-up of the DGGT cohort in the EDIC study, regarding the persistent effects of intensive treatment on reducing the microvascular complications of type 1 diabetes.
    • (2002) JAMA , vol.287 , pp. 2563-2569
  • 19
    • 0033946110 scopus 로고    scopus 로고
    • Increased circulating nitric oxide in young patients with type 1 diabetes and persistent microalbuminuria: Relation to glomerular hyperfiltration
    • Chiarelli F, Cipollone F, Romano F, et al. Increased circulating nitric oxide in young patients with type 1 diabetes and persistent microalbuminuria: relation to glomerular hyperfiltration. Diabetes 2000; 49:1258-1263.
    • (2000) Diabetes , vol.49 , pp. 1258-1263
    • Chiarelli, F.1    Cipollone, F.2    Romano, F.3
  • 20
    • 0036363163 scopus 로고    scopus 로고
    • Chronic diabetic nephropathy: Role of inducible nitric oxide synthase
    • Trachtman H, Futterweit S, Pine E, et al. Chronic diabetic nephropathy: role of inducible nitric oxide synthase. Pediatr Nephrol 2002; 17:20-29.
    • (2002) Pediatr Nephrol , vol.17 , pp. 20-29
    • Trachtman, H.1    Futterweit, S.2    Pine, E.3
  • 21
    • 0036189833 scopus 로고    scopus 로고
    • Decreased matrix degradation in diabetic nephropathy: Effects of ACE inhibition on the expression and activities of matrix metalloproteinases
    • McLennan SV, Kelly DJ, Cox AJ, et al. Decreased matrix degradation in diabetic nephropathy: effects of ACE inhibition on the expression and activities of matrix metalloproteinases. Diabetologia 2002; 45:268-275.
    • (2002) Diabetologia , vol.45 , pp. 268-275
    • McLennan, S.V.1    Kelly, D.J.2    Cox, A.J.3
  • 22
    • 0036020933 scopus 로고    scopus 로고
    • Expression of the slit-diaphragm protein, nephrin, in experimental diabetic nephropathy: Differing effects of anti-proteinuric therapies
    • Kelly DJ, Aaltonen P, Cox AJ, et al. Expression of the slit-diaphragm protein, nephrin, in experimental diabetic nephropathy: differing effects of anti-proteinuric therapies. Nephrol Dial Transplant 2002; 17:1327-1332.
    • (2002) Nephrol Dial Transplant , vol.17 , pp. 1327-1332
    • Kelly, D.J.1    Aaltonen, P.2    Cox, A.J.3
  • 23
    • 0036433059 scopus 로고    scopus 로고
    • Proteinuria and the expression of the podocyte slit diaphragm protein, nephrin, in diabetic nephropathy: Effects of angiotensin converting enzyme inhibition
    • Langham RG, Kelly DJ, Cox AJ, et al. Proteinuria and the expression of the podocyte slit diaphragm protein, nephrin, in diabetic nephropathy: effects of angiotensin converting enzyme inhibition. Diabetologia 2002; 45:1572-1576.
    • (2002) Diabetologia , vol.45 , pp. 1572-1576
    • Langham, R.G.1    Kelly, D.J.2    Cox, A.J.3
  • 24
    • 0035987906 scopus 로고    scopus 로고
    • Renoprotective effects of valsartan and enalapril in STZ-induced diabetes in rats
    • Kalender B, Ozturk M, Tuncdemir M, et al. Renoprotective effects of valsartan and enalapril in STZ-induced diabetes in rats. Acta Histochem 2002; 104:123-130.
    • (2002) Acta Histochem , vol.104 , pp. 123-130
    • Kalender, B.1    Ozturk, M.2    Tuncdemir, M.3
  • 25
    • 0036236554 scopus 로고    scopus 로고
    • Renoprotective effects of blockade of angiotensin II AT1 receptors in an animal model of type 2 diabetes
    • Mizuno M, Sada T, Kato M, et al. Renoprotective effects of blockade of angiotensin II AT1 receptors in an animal model of type 2 diabetes. Hypertens Res 2002; 25:271-278.
    • (2002) Hypertens Res , vol.25 , pp. 271-278
    • Mizuno, M.1    Sada, T.2    Kato, M.3
  • 26
    • 0036596686 scopus 로고    scopus 로고
    • Urinary transforming growth factor-beta excretion in patients with hypertension, type 2 diabetes, and elevated albumin excretion rate: Effects of angiotensin receptor blockade and sodium restriction
    • Houlihan CA, Akdeniz A, Tsalamandris C, et al. Urinary transforming growth factor-beta excretion in patients with hypertension, type 2 diabetes, and elevated albumin excretion rate: effects of angiotensin receptor blockade and sodium restriction. Diabetes Care 2002; 25:1072-1077.
    • (2002) Diabetes Care , vol.25 , pp. 1072-1077
    • Houlihan, C.A.1    Akdeniz, A.2    Tsalamandris, C.3
  • 27
    • 0036723888 scopus 로고    scopus 로고
    • Nephropathy in siblings of African Americans with overt type 2 diabetic nephropathy
    • Satko SG, Langefeld CD, Daeihagh P, et al. Nephropathy in siblings of African Americans with overt type 2 diabetic nephropathy. Am J Kidney Dis 2002: 40:489-494. Describes the prevalence of nephropathy in a large number of diabetic sibling pairs from African American families with type 2 diabetes and overt diabetic nephropathy.
    • (2002) Am J Kidney Dis , vol.40 , pp. 489-494
    • Satko, S.G.1    Langefeld, C.D.2    Daeihagh, P.3
  • 28
    • 17744421301 scopus 로고    scopus 로고
    • Gene for susceptibility to diabetic nephropathy in type 2 diabetes maps to 18q22.3-23
    • Vardarli I, Baier LJ, Hanson RL, et al. Gene for susceptibility to diabetic nephropathy in type 2 diabetes maps to 18q22.3-23. Kidney Int 2002; 62:2176-2183.
    • (2002) Kidney Int , vol.62 , pp. 2176-2183
    • Vardarli, I.1    Baier, L.J.2    Hanson, R.L.3
  • 29
    • 0036181795 scopus 로고    scopus 로고
    • Relationship between polymorphisms in the renin-angiotensin system and nephropathy in type 2 diabetic patients
    • Fradin S, Goulet-Salmon B, Chantepie M, et al. Relationship between polymorphisms in the renin-angiotensin system and nephropathy in type 2 diabetic patients. Diabetes Metab 2002; 28:27-32.
    • (2002) Diabetes Metab , vol.28 , pp. 27-32
    • Fradin, S.1    Goulet-Salmon, B.2    Chantepie, M.3
  • 30
    • 0035992566 scopus 로고    scopus 로고
    • ACE and PC-1 gene polymorphisms in normoalbuminuric Type 1 diabetic patients: A 10-year prospective study
    • de Azevedo MJ, Dalmaz CA, Caramori ML, et al. ACE and PC-1 gene polymorphisms in normoalbuminuric Type 1 diabetic patients: a 10-year prospective study. J Diabetes Complications 2002; 16:255-262.
    • (2002) J Diabetes Complications , vol.16 , pp. 255-262
    • De Azevedo, M.J.1    Dalmaz, C.A.2    Caramori, M.L.3
  • 31
    • 0035993273 scopus 로고    scopus 로고
    • The role of PC-1 and ACE genes in diabetic nephropathy in type 1 diabetic patients: Evidence for a polygenic control of kidney disease progression
    • De Cosmo S, Miscio G, Zucaro L, et al. The role of PC-1 and ACE genes in diabetic nephropathy in type 1 diabetic patients: evidence for a polygenic control of kidney disease progression. Nephrol Dial Transplant 2002; 17:1402-1407. Investigates ACE and ENPP1 (PC-1) polymorphisms as predictors of development or progression of diabetic nephropathy in type 1 diabetic patients.
    • (2002) Nephrol Dial Transplant , vol.17 , pp. 1402-1407
    • De Cosmo, S.1    Miscio, G.2    Zucaro, L.3
  • 32
    • 0036332371 scopus 로고    scopus 로고
    • Angiotensin converting enzyme gene polymorphism and glomerular filtration rate changes in type 2 diabetic patients
    • Araz M, Okan V, Celen Z, et al. Angiotensin converting enzyme gene polymorphism and glomerular filtration rate changes in type 2 diabetic patients. Int J Clin Pract 2002; 56:416-418.
    • (2002) Int J Clin Pract , vol.56 , pp. 416-418
    • Araz, M.1    Okan, V.2    Celen, Z.3
  • 33
    • 0036097534 scopus 로고    scopus 로고
    • The angiotensin-converting enzyme DD genotype is associated with glomerulopathy lesions in type 2 diabetes
    • Solini A, Dalla Vestra M, Saller A, et al. The angiotensin-converting enzyme DD genotype is associated with glomerulopathy lesions in type 2 diabetes. Diabetes 2002; 51:251-255. Explores the relationship between diabetic glomerulopathy and ACE genotype in microalbuminuric and proteinuric type 2 diabetic patients.
    • (2002) Diabetes , vol.51 , pp. 251-255
    • Solini, A.1    Dalla Vestra, M.2    Saller, A.3
  • 34
    • 0036011343 scopus 로고    scopus 로고
    • Bradykinin B2 receptor gene polymorphism is associated with altered urinary albumin/creatinine values in diabetic patients
    • Maltais I, Bachvarova M, Maheux P, et al. Bradykinin B2 receptor gene polymorphism is associated with altered urinary albumin/creatinine values in diabetic patients. Can J Physiol Pharmacol 2002; 80:323-327.
    • (2002) Can J Physiol Pharmacol , vol.80 , pp. 323-327
    • Maltais, I.1    Bachvarova, M.2    Maheux, P.3
  • 35
    • 0036231891 scopus 로고    scopus 로고
    • Polymorphism in ecto-nucleotide pyrophosphatase/phosphodiesterase 1 gene (ENPP1/PC-1) and early development of advanced diabetic nephropathy in type 1 diabetes
    • Canani LH, Ng DP, Smiles A, et al. Polymorphism in ecto-nucleotide pyrophosphatase/phosphodiesterase 1 gene (ENPP1/PC-1) and early development of advanced diabetic nephropathy in type 1 diabetes. Diabetes 2002; 51:1188-1193. This describes the results of a case-control study and a family-based study evaluating the association between ecto-nucleotide pyrophosphatase/phosphodiesterase 1 gene polymorphism and advanced diabetic nephropathy in patients with type 1 diabetes.
    • (2002) Diabetes , vol.51 , pp. 1188-1193
    • Canani, L.H.1    Ng, D.P.2    Smiles, A.3
  • 36
    • 0036426805 scopus 로고    scopus 로고
    • Nephropathy in type 1 diabetes: A manifestation of insulin resistance and multiple genetic susceptibilities? Further evidence from the Pittsburgh Epidemiology of Diabetes Complication Study
    • Orchard TJ, Chang YF, Ferrell RE, et al. Nephropathy in type 1 diabetes: a manifestation of insulin resistance and multiple genetic susceptibilities? Further evidence from the Pittsburgh Epidemiology of Diabetes Complication Study. Kidney Int 2002; 62:963-970. The authors evaluated the role of insulin resistance and other variables as predictors of overt diabetic nephropathy in a large cohort of type 1 diabetic patients.
    • (2002) Kidney Int , vol.62 , pp. 963-970
    • Orchard, T.J.1    Chang, Y.F.2    Ferrell, R.E.3
  • 37
    • 0033651349 scopus 로고    scopus 로고
    • APOE polymorphisms and the development of diabetic nephropathy in type 1 diabetes: Results of case-control and family-based studies
    • Araki S, Moczulski DK, Hanna L, et al. APOE polymorphisms and the development of diabetic nephropathy in type 1 diabetes: results of case-control and family-based studies. Diabetes 2000; 49:2190-2195.
    • (2000) Diabetes , vol.49 , pp. 2190-2195
    • Araki, S.1    Moczulski, D.K.2    Hanna, L.3
  • 38
    • 0036328342 scopus 로고    scopus 로고
    • Apolipoprotein E genetic polymorphism, remnant lipoproteins, and nephropathy in type 2 diabetic patients
    • Eto M, Saito M, Okada M, et al. Apolipoprotein E genetic polymorphism, remnant lipoproteins, and nephropathy in type 2 diabetic patients. Am J Kidney Dis 2002; 40:243-251.
    • (2002) Am J Kidney Dis , vol.40 , pp. 243-251
    • Eto, M.1    Saito, M.2    Okada, M.3
  • 39
    • 0036659004 scopus 로고    scopus 로고
    • Higher frequency of apolipoprotein E2 allele in type 2 diabetic patients with nephropathy in Taiwan
    • Hsieh MC, Lin SR, Yang YC, et al. Higher frequency of apolipoprotein E2 allele in type 2 diabetic patients with nephropathy in Taiwan. J Nephrol 2002; 15:368-373.
    • (2002) J Nephrol , vol.15 , pp. 368-373
    • Hsieh, M.C.1    Lin, S.R.2    Yang, Y.C.3
  • 40
    • 0036320727 scopus 로고    scopus 로고
    • Peroxisome proliferator-activated receptor-gamma2 polymorphism Pro12Ala is associated with nephropathy in type 2 diabetes: The Berlin Diabetes Mellitus (BeDiaM) Study
    • Herrmann SM, Ringel J, Wang JG, et al. Peroxisome proliferator-activated receptor-gamma2 polymorphism Pro12Ala is associated with nephropathy in type 2 diabetes: The Berlin Diabetes Mellitus (BeDiaM) Study. Diabetes 2002; 51:2653-2657. The results of this study suggested an association between the PPAR-γ2 Pro12Ala polymorphism and decreased risk of diabetic nephropathy in patients with type 2 diabetes.
    • (2002) Diabetes , vol.51 , pp. 2653-2657
    • Herrmann, S.M.1    Ringel, J.2    Wang, J.G.3
  • 41
    • 0036097735 scopus 로고    scopus 로고
    • Chemokine receptor genotype is associated with diabetic nephropathy in Japanese with type 2 diabetes
    • Nakajima K, Tanaka Y, Nomiyama T, et al. Chemokine receptor genotype is associated with diabetic nephropathy in Japanese with type 2 diabetes. Diabetes 2002; 51:238-242.
    • (2002) Diabetes , vol.51 , pp. 238-242
    • Nakajima, K.1    Tanaka, Y.2    Nomiyama, T.3
  • 42
    • 0036741894 scopus 로고    scopus 로고
    • Leukocyte-endothelial cell adhesion molecule 1 (LECAM-1) polymorphism is associated with diabetic nephropathy in type 2 diabetes mellitus
    • Kamiuchi K, Hasegawa G, Obayashi H, et al. Leukocyte-endothelial cell adhesion molecule 1 (LECAM-1) polymorphism is associated with diabetic nephropathy in type 2 diabetes mellitus. J Diabetes Complications 2002; 16:333-337.
    • (2002) J Diabetes Complications , vol.16 , pp. 333-337
    • Kamiuchi, K.1    Hasegawa, G.2    Obayashi, H.3
  • 43
    • 0036300030 scopus 로고    scopus 로고
    • Minor effect of GLUT1 polymorphisms on susceptibility to diabetic nephropathy in type 1 diabetes
    • Ng DP, Canani L, Araki S, et al. Minor effect of GLUT1 polymorphisms on susceptibility to diabetic nephropathy in type 1 diabetes. Diabetes 2002; 51:2264-2269. These authors report an association between GLUT-1 polymorphisms and increased risk of diabetic nephropathy in a subset of type 1 diabetic patients.
    • (2002) Diabetes , vol.51 , pp. 2264-2269
    • Ng, D.P.1    Canani, L.2    Araki, S.3
  • 44
    • 0032143644 scopus 로고    scopus 로고
    • GLUT1 gene polymorphism in noninsulin-dependent diabetes mellitus: Genetic susceptibility relationship with cardiovascular risk factors and microangiopathic complications in a Mediterranean population
    • Gutierrez C, Vendrell J, Pastor R, et al. GLUT1 gene polymorphism in noninsulin-dependent diabetes mellitus: genetic susceptibility relationship with cardiovascular risk factors and microangiopathic complications in a Mediterranean population. Diabetes Res Clin Pract 1998; 41:113-120.
    • (1998) Diabetes Res Clin Pract , vol.41 , pp. 113-120
    • Gutierrez, C.1    Vendrell, J.2    Pastor, R.3
  • 45
    • 0036182269 scopus 로고    scopus 로고
    • Association of a functional inducible nitric oxide synthase promoter variant with complications in type 2 diabetes
    • Morris BJ, Markus A, Glenn CL, et al. Association of a functional inducible nitric oxide synthase promoter variant with complications in type 2 diabetes. J Mol Med 2002; 80:96-104.
    • (2002) J Mol Med , vol.80 , pp. 96-104
    • Morris, B.J.1    Markus, A.2    Glenn, C.L.3
  • 46
    • 0036230806 scopus 로고    scopus 로고
    • Paraoxonase gene cluster is a genetic marker for early microvascular complications in type 1 diabetes
    • Kao Y, Donaghue KC, Chan A, et al. Paraoxonase gene cluster is a genetic marker for early microvascular complications in type 1 diabetes. Diabet Med 2002; 19:212-215.
    • (2002) Diabet Med , vol.19 , pp. 212-215
    • Kao, Y.1    Donaghue, K.C.2    Chan, A.3
  • 47
    • 0036972917 scopus 로고    scopus 로고
    • Endothelial nitric oxide synthase gene and the development of diabetic nephropathy
    • Shimizu T, Onuma T, Kawamori R, et al. Endothelial nitric oxide synthase gene and the development of diabetic nephropathy. Diabetes Res Clin Pract 2002; 58:179-185.
    • (2002) Diabetes Res Clin Pract , vol.58 , pp. 179-185
    • Shimizu, T.1    Onuma, T.2    Kawamori, R.3
  • 48
    • 0036125236 scopus 로고    scopus 로고
    • Diabetic nephropathy is associated with the 5′-end dinucleotide repeat polymorphism of the aldose reductase gene in Chinese subjects with Type 2 diabetes
    • Liu YF, Wat NM, Chung SS, et al. Diabetic nephropathy is associated with the 5′-end dinucleotide repeat polymorphism of the aldose reductase gene in Chinese subjects with Type 2 diabetes. Diabet Med 2002; 19:113-118.
    • (2002) Diabet Med , vol.19 , pp. 113-118
    • Liu, Y.F.1    Wat, N.M.2    Chung, S.S.3
  • 49
    • 0036143666 scopus 로고    scopus 로고
    • (AC)(n) polymorphism of aldose reductase gene and diabetic microvascular complications in type 2 diabetes mellitus
    • Park HK, Ahn CW, Lee GT, et al. (AC)(n) polymorphism of aldose reductase gene and diabetic microvascular complications in type 2 diabetes mellitus. Diabetes Res Clin Pract 2002; 55:151-157.
    • (2002) Diabetes Res Clin Pract , vol.55 , pp. 151-157
    • Park, H.K.1    Ahn, C.W.2    Lee, G.T.3
  • 50
    • 18544388557 scopus 로고    scopus 로고
    • The Decorin gene 179 allelic variant is associated with a slower progression of renal disease in patients with type 1 diabetes
    • De Cosmo S, Tassi V, Thomas S, et al. The Decorin gene 179 allelic variant is associated with a slower progression of renal disease in patients with type 1 diabetes. Nephron 2002; 92:72-76.
    • (2002) Nephron , vol.92 , pp. 72-76
    • De Cosmo, S.1    Tassi, V.2    Thomas, S.3
  • 51
    • 0036380319 scopus 로고    scopus 로고
    • Mesangial cell-predominant gene, megsin
    • Inagi R, Miyata T, Imasawa T, et al. Mesangial cell-predominant gene, megsin. Nephrol Dial Transplant 2002; 17 (Suppl 9):32-33.
    • (2002) Nephrol Dial Transplant , vol.17 , Issue.SUPPL. 9 , pp. 32-33
    • Inagi, R.1    Miyata, T.2    Imasawa, T.3
  • 52
    • 0036717048 scopus 로고    scopus 로고
    • Role of nephrin in renal disease including diabetic nephropathy
    • Cooper ME, Mundel P, Boner G. Role of nephrin in renal disease including diabetic nephropathy. Semin Nephrol 2002; 22:393-398.
    • (2002) Semin Nephrol , vol.22 , pp. 393-398
    • Cooper, M.E.1    Mundel, P.2    Boner, G.3
  • 53
    • 0035991118 scopus 로고    scopus 로고
    • Gremlins: Is this what renal fibrogenesis has come to?
    • Murphy M, McMahon R, Lappin DW, et al. Gremlins: is this what renal fibrogenesis has come to? Exp Nephrol 2002; 10:241-244.
    • (2002) Exp Nephrol , vol.10 , pp. 241-244
    • Murphy, M.1    McMahon, R.2    Lappin, D.W.3
  • 54
    • 0036385254 scopus 로고    scopus 로고
    • Gremlin: An example of the reemergence of developmental programmes in diabetic nephropathy
    • Lappin DW, McMahon R, Murphy M, et al. Gremlin: an example of the reemergence of developmental programmes in diabetic nephropathy. Nephrol Dial Transplant 2002; 17 (Suppl 9):65-67.
    • (2002) Nephrol Dial Transplant , vol.17 , Issue.SUPPL. 9 , pp. 65-67
    • Lappin, D.W.1    McMahon, R.2    Murphy, M.3
  • 55
    • 0036177882 scopus 로고    scopus 로고
    • Gene expression and identification of gene therapy targets in diabetic nephropathy
    • Wada J, Makino H, Kanwar YS. Gene expression and identification of gene therapy targets in diabetic nephropathy. Kidney Int Suppl 2002; 61 (Suppl 1):73-78.
    • (2002) Kidney Int Suppl , vol.61 , Issue.SUPPL. 1 , pp. 73-78
    • Wada, J.1    Makino, H.2    Kanwar, Y.S.3
  • 56
    • 0037920442 scopus 로고    scopus 로고
    • Pathophysiology of renal complications
    • Porte D, editor. New York: McGraw-Hill
    • Caramori MLA, Mauer M. Pathophysiology of renal complications. In: Porte D, editor. Ellemberg & Rifkin's diabetes mellitus. 6th ed. New York: McGraw-Hill; 2002. pp. 697-721. This is a thorough review on the pathophysiology of diabetic nephropathy.
    • (2002) Ellemberg & Rifkin's Diabetes Mellitus. 6th Ed. , pp. 697-721
    • Caramori, M.L.A.1    Mauer, M.2
  • 57
    • 0036829908 scopus 로고    scopus 로고
    • High glucose stimulates synthesis of fibronectin via a novel protein kinase C, Rap1b, and B-Raf signaling pathway
    • Lin S, Sahai A, Chugh SS, et al. High glucose stimulates synthesis of fibronectin via a novel protein kinase C, Rap1b, and B-Raf signaling pathway. J Biol Chem 2002; 277:41725-41735. This study suggested a novel pathway associated with high glucose-induced mesangial matrix synthesis.
    • (2002) J Biol Chem , vol.277 , pp. 41725-41735
    • Lin, S.1    Sahai, A.2    Chugh, S.S.3
  • 58
    • 0033814068 scopus 로고    scopus 로고
    • Role of growth factors in the development of diabetic complications
    • Chiarelli F, Santilli F, Mohn A. Role of growth factors in the development of diabetic complications. Horm Res 2000; 53:53-67.
    • (2000) Horm Res , vol.53 , pp. 53-67
    • Chiarelli, F.1    Santilli, F.2    Mohn, A.3
  • 59
    • 0036735194 scopus 로고    scopus 로고
    • Independent regulation of transforming growth factor-beta1 transcription and translation by glucose and platelet-derived growth factor
    • Fraser D, Wakefield L, Phillips A. Independent regulation of transforming growth factor-beta1 transcription and translation by glucose and platelet-derived growth factor. Am J Pathol 2002; 161:1039-1049.
    • (2002) Am J Pathol , vol.161 , pp. 1039-1049
    • Fraser, D.1    Wakefield, L.2    Phillips, A.3
  • 60
    • 0036786249 scopus 로고    scopus 로고
    • Connective tissue growth factor and regulation of the mesangial cell cycle: Role in cellular hypertrophy
    • Abdel-Wahab N, Weston BS, Roberts T, et al. Connective tissue growth factor and regulation of the mesangial cell cycle: role in cellular hypertrophy. J Am Soc Nephrol 2002; 13:2437-2445. These investigators evaluated the effects of CTGF on mesangial cell cycle.
    • (2002) J Am Soc Nephrol , vol.13 , pp. 2437-2445
    • Abdel-Wahab, N.1    Weston, B.S.2    Roberts, T.3
  • 61
    • 0033760187 scopus 로고    scopus 로고
    • AP-1 proteins mediate hyperglycemia-induced activation of the human TGF-beta1 promoter in mesangial cells
    • Weigert C, Sauer U, Brodbeck K, et al. AP-1 proteins mediate hyperglycemia-induced activation of the human TGF-beta1 promoter in mesangial cells. J Am Soc Nephrol 2000; 11:2007-2016.
    • (2000) J Am Soc Nephrol , vol.11 , pp. 2007-2016
    • Weigert, C.1    Sauer, U.2    Brodbeck, K.3
  • 62
    • 0036895640 scopus 로고    scopus 로고
    • Cellular basis of diabetic nephropathy: II. The transforming growth factor-beta system and diabetic nephropathy lesions in type 1 diabetes
    • Huang C, Kim Y, Caramori ML, et al. Cellular basis of diabetic nephropathy: II. The transforming growth factor-beta system and diabetic nephropathy lesions in type 1 diabetes. Diabetes 2002; 51:3577-3581. This describes differences in messenger RNA expression levels of TGF-β system components in cultured skin fibroblasts from type 1 diabetic patients with fast versus slow development of diabetic nephropathy lesions.
    • (2002) Diabetes , vol.51 , pp. 3577-3581
    • Huang, C.1    Kim, Y.2    Caramori, M.L.3
  • 63
    • 0036086797 scopus 로고    scopus 로고
    • Upregulation of type I collagen by TGF-beta in mesangial cells is blocked by PPARgamma activation
    • Zheng F, Fornoni A, Elliot SJ, et al. Upregulation of type I collagen by TGF-beta in mesangial cells is blocked by PPARgamma activation. Am J Physiol Renal Physiol 2002; 282:F639-F648. The study examined the regulation of type I collagen expression by PPARγ and TGF-β1 in mouse mesangial cells exposed to normal and high glucose.
    • (2002) Am J Physiol Renal Physiol , vol.282
    • Zheng, F.1    Fornoni, A.2    Elliot, S.J.3
  • 64
    • 0036098955 scopus 로고    scopus 로고
    • Microangiopathic injury and augmented PAI-1 in human diabetic nephropathy
    • Paueksakon P, Revelo MP, Ma LJ, et al. Microangiopathic injury and augmented PAI-1 in human diabetic nephropathy. Kidney Int 2002; 61:2142-2148. This evaluated the role of plasminogen activator inhibitor-1 and PPARγ on diabetic nephropathy microvascular injury.
    • (2002) Kidney Int , vol.61 , pp. 2142-2148
    • Paueksakon, P.1    Revelo, M.P.2    Ma, L.J.3
  • 65
    • 33751299571 scopus 로고    scopus 로고
    • Effects of high glucose on vascular endothelial growth factor expression in vascular smooth muscle cells
    • Natarajan R, Bai W, Lanting L, et al. Effects of high glucose on vascular endothelial growth factor expression in vascular smooth muscle cells. Am J Physiol Heart Circ Physiol 1997; 273:H2224-H2231.
    • (1997) Am J Physiol Heart Circ Physiol , vol.273
    • Natarajan, R.1    Bai, W.2    Lanting, L.3
  • 66
    • 0033851522 scopus 로고    scopus 로고
    • Role of vascular endothelial growth factor in diabetic nephropathy
    • Cha DR, Kim NH, Yoon JW, et al. Role of vascular endothelial growth factor in diabetic nephropathy. Kidney Int 2000; 58 (Suppl 77):S104-S112.
    • (2000) Kidney Int , vol.58 , Issue.SUPPL. 77
    • Cha, D.R.1    Kim, N.H.2    Yoon, J.W.3
  • 67
    • 0034046347 scopus 로고    scopus 로고
    • Expression of vascular endothelial growth factor in response to high glucose in rat mesangial cells
    • Kim NH, Jung HH, Cha DR, et al. Expression of vascular endothelial growth factor in response to high glucose in rat mesangial cells. J Endocrinol 2000; 165:617-624.
    • (2000) J Endocrinol , vol.165 , pp. 617-624
    • Kim, N.H.1    Jung, H.H.2    Cha, D.R.3
  • 68
    • 0036289551 scopus 로고    scopus 로고
    • High glucose induced VEGF expression via PKC and ERK in glomerular podocytes
    • Hoshi S, Nomoto K, Kuromitsu J, et al. High glucose induced VEGF expression via PKC and ERK in glomerular podocytes. Biochem Biophys Res Commun 2002; 290:177-184. These authors investigated the role of PKC and extracellular signal-regulated kinase on high glucose-induced podocyte vascular endothelial growth factor expression.
    • (2002) Biochem Biophys Res Commun , vol.290 , pp. 177-184
    • Hoshi, S.1    Nomoto, K.2    Kuromitsu, J.3
  • 69
    • 0030863502 scopus 로고    scopus 로고
    • Glucose-induced protein kinase C activation regulates vascular permeability factor mRNA expression and peptide production by human vascular smooth muscle cells in vitro
    • Williams B, Gallacher B, Patel H, et al. Glucose-induced protein kinase C activation regulates vascular permeability factor mRNA expression and peptide production by human vascular smooth muscle cells in vitro. Diabetes 1997; 46:1497-1503.
    • (1997) Diabetes , vol.46 , pp. 1497-1503
    • Williams, B.1    Gallacher, B.2    Patel, H.3
  • 70
    • 0036789207 scopus 로고    scopus 로고
    • Amelioration of long-term renal changes in obese type 2 diabetic mice by a neutralizing vascular endothelial growth factor antibody
    • Flyvbjerg A, Dagnaes-Hansen F, De Vriese AS, et al. Amelioration of long-term renal changes in obese type 2 diabetic mice by a neutralizing vascular endothelial growth factor antibody. Diabetes 2002; 51:3090-3094. This examines the effects of a neutralizing vascular endothelial growth factor antibody on renal structure and function of db/db diabetic mice.
    • (2002) Diabetes , vol.51 , pp. 3090-3094
    • Flyvbjerg, A.1    Dagnaes-Hansen, F.2    De Vriese, A.S.3
  • 71
    • 0036183786 scopus 로고    scopus 로고
    • High glucose down-regulates angiotensin II binding via the PKC-MAPK-cPLA2 signal cascade in renal proximal tubule cells
    • Park SH, Woo CH, Kim JH, et al. High glucose down-regulates angiotensin II binding via the PKC-MAPK-cPLA2 signal cascade in renal proximal tubule cells. Kidney Int 2002; 61:913-925. This study evaluated the effects of high glucose on arachidonic acid and angiotensin II binding in renal proximal tubular cells.
    • (2002) Kidney Int , vol.61 , pp. 913-925
    • Park, S.H.1    Woo, C.H.2    Kim, J.H.3
  • 72
    • 0036083521 scopus 로고    scopus 로고
    • The mechanism of angiotensin II binding downregulation by high glucose in primary renal proximal tubule cells
    • Park SH, Han HJ. The mechanism of angiotensin II binding downregulation by high glucose in primary renal proximal tubule cells. Am J Physiol Renal Physiol 2002; 282:F228-F237. The authors investigated the signal pathways involved in high-glucose-induced downregulation of angiotensin II binding in renal proximal tubular cells.
    • (2002) Am J Physiol Renal Physiol , vol.282
    • Park, S.H.1    Han, H.J.2
  • 73
    • 0036236158 scopus 로고    scopus 로고
    • Angiotensin II activation of the JAK/STAT pathway in mesangial cells is altered by high glucose
    • Amiri F, Shaw S, Wang X, et al. Angiotensin II activation of the JAK/STAT pathway in mesangial cells is altered by high glucose. Kidney Int 2002; 61:1605-1616.
    • (2002) Kidney Int , vol.61 , pp. 1605-1616
    • Amiri, F.1    Shaw, S.2    Wang, X.3
  • 74
    • 0036597884 scopus 로고    scopus 로고
    • Angiotensin II induces human TGF-beta 1 promoter activation: Similarity to hyperglycaemia
    • Weigert C, Brodbeck K, Klopfer K, et al. Angiotensin II induces human TGF-beta 1 promoter activation: similarity to hyperglycaemia. Diabetologia 2002; 45:890-898. In this paper the authors describe the molecular mechanism of angiotensin II-induced TGF-β1 gene activation in mesangial cells.
    • (2002) Diabetologia , vol.45 , pp. 890-898
    • Weigert, C.1    Brodbeck, K.2    Klopfer, K.3
  • 75
    • 0036149122 scopus 로고    scopus 로고
    • Attenuation of tubular apoptosis by blockade of the renin-angiotensin system in diabetic Ren-2 rats
    • Kelly DJ, Cox AJ, Tolcos M, et al. Attenuation of tubular apoptosis by blockade of the renin-angiotensin system in diabetic Ren-2 rats. Kidney Int 2002; 61:31-39.
    • (2002) Kidney Int , vol.61 , pp. 31-39
    • Kelly, D.J.1    Cox, A.J.2    Tolcos, M.3
  • 76
    • 18644365067 scopus 로고    scopus 로고
    • Changes of endothelin in streptozotocin-induced diabetic rats: Effects of an angiotensin converting enzyme inhibitor, enalapril maleate
    • Itoh Y, Imamura S, Yamamoto K, et al. Changes of endothelin in streptozotocin-induced diabetic rats: effects of an angiotensin converting enzyme inhibitor, enalapril maleate. J Endocrinol 2002; 175:233-239.
    • (2002) J Endocrinol , vol.175 , pp. 233-239
    • Itoh, Y.1    Imamura, S.2    Yamamoto, K.3
  • 77
    • 0036073109 scopus 로고    scopus 로고
    • High glucose-enhanced activation of mesangial cell p38 MAPK by ET-1, ANG II, and platelet-derived growth factor
    • Tsiani E, Lekas P, Fantus IG, et al. High glucose-enhanced activation of mesangial cell p38 MAPK by ET-1, ANG II, and platelet-derived growth factor. Am J Physiol Endocrinol Metab 2002; 282:E161-E169.
    • (2002) Am J Physiol Endocrinol Metab , vol.282
    • Tsiani, E.1    Lekas, P.2    Fantus, I.G.3
  • 78
    • 0036839201 scopus 로고    scopus 로고
    • Interaction of MAPK and 12-lipoxygenase pathways in growth and matrix protein expression in mesangial cells
    • Reddy MA, Adler SG, Kim YS, et al. Interaction of MAPK and 12-lipoxygenase pathways in growth and matrix protein expression in mesangial cells. Am J Physiol Renal Physiol 2002; 283:F985-F994. This suggests a novel interaction between lipoxygenase and p38 mitogen-activated protein kinase, and its association with diabetic nephropathy.
    • (2002) Am J Physiol Renal Physiol , vol.283
    • Reddy, M.A.1    Adler, S.G.2    Kim, Y.S.3
  • 79
    • 0037162699 scopus 로고    scopus 로고
    • Renal protective effect of YM598, a selective endothelin ET(A) receptor antagonist, against diabetic nephropathy in OLETF rats
    • Sugimoto K, Tsuruoka S, Fujimura A. Renal protective effect of YM598, a selective endothelin ET(A) receptor antagonist, against diabetic nephropathy in OLETF rats. Eur J Pharmacol 2002; 450:183-189.
    • (2002) Eur J Pharmacol , vol.450 , pp. 183-189
    • Sugimoto, K.1    Tsuruoka, S.2    Fujimura, A.3
  • 80
    • 0031724557 scopus 로고    scopus 로고
    • Urinary endothelin in adolescents and young adults with insulin-dependent diabetes mellitus: Relation to urinary albumin, blood pressure, and other factors
    • Peppa-Patrikiou M, Dracopoulou M, Dacou-Voutetakis C. Urinary endothelin in adolescents and young adults with insulin-dependent diabetes mellitus: relation to urinary albumin, blood pressure, and other factors. Metabolism 1998; 47:1408-1412.
    • (1998) Metabolism , vol.47 , pp. 1408-1412
    • Peppa-Patrikiou, M.1    Dracopoulou, M.2    Dacou-Voutetakis, C.3
  • 81
    • 0029834396 scopus 로고    scopus 로고
    • The correlation of plasma and urine endothelin-1 with the severity of nephropathy in Chinese patients with type 2 diabetes
    • Shin SJ, Lee YJ, Tsai JH. The correlation of plasma and urine endothelin-1 with the severity of nephropathy in Chinese patients with type 2 diabetes. Scand J Clin Lab Invest 1996; 56:571-576.
    • (1996) Scand J Clin Lab Invest , vol.56 , pp. 571-576
    • Shin, S.J.1    Lee, Y.J.2    Tsai, J.H.3
  • 82
    • 0036024034 scopus 로고    scopus 로고
    • Plasma endothelin-1 levels and albumin excretion rate in normotensive, microalbuminuric type 2 diabetic patients
    • Bruno CM, Meli S, Marcinno M, et al. Plasma endothelin-1 levels and albumin excretion rate in normotensive, microalbuminuric type 2 diabetic patients. J Biol Regul Homeost Agents 2002; 16:114-117.
    • (2002) J Biol Regul Homeost Agents , vol.16 , pp. 114-117
    • Bruno, C.M.1    Meli, S.2    Marcinno, M.3
  • 83
    • 0036998009 scopus 로고    scopus 로고
    • Serum angiogenin concentrations in young patients with diabetes mellitus
    • Chiarelli F, Pomilio M, Mohn A, et al. Serum angiogenin concentrations in young patients with diabetes mellitus. Eur J Clin Invest 2002; 32:110-114.
    • (2002) Eur J Clin Invest , vol.32 , pp. 110-114
    • Chiarelli, F.1    Pomilio, M.2    Mohn, A.3
  • 84
    • 0036084953 scopus 로고    scopus 로고
    • Alterations in renal mitochondrial respiration in response to the reactive oxoaldehyde methylglyoxal
    • Rosca MG, Monnier VM, Szweda LI, et al. Alterations in renal mitochondrial respiration in response to the reactive oxoaldehyde methylglyoxal. Am J Physiol Renal Physiol 2002; 283:F52-F59. The authors evaluated the toxic effects of methylglyoxal in renal mitochondria.
    • (2002) Am J Physiol Renal Physiol , vol.283
    • Rosca, M.G.1    Monnier, V.M.2    Szweda, L.I.3
  • 85
    • 0036317040 scopus 로고    scopus 로고
    • Accumulation of 8-hydroxy-2′-deoxyguanosine and mitochondrial DNA deletion in kidney of diabetic rats
    • Kakimoto M, Inoguchi T, Sonta T, et al. Accumulation of 8-hydroxy-2′-deoxyguanosine and mitochondrial DNA deletion in kidney of diabetic rats. Diabetes 2002; 51:1588-1595. This paper resports a dissection of the molecular mechanisms of oxidative mitochondrial DNA damage in diabetic rat kidneys.
    • (2002) Diabetes , vol.51 , pp. 1588-1595
    • Kakimoto, M.1    Inoguchi, T.2    Sonta, T.3
  • 86
    • 0036151673 scopus 로고    scopus 로고
    • Glucose-induced oxidative stress in mesangial cells
    • Catherwood MA, Powell LA, Anderson P, et al. Glucose-induced oxidative stress in mesangial cells. Kidney Int 2002; 61:599-608. This investigates the effects of high glucose and antioxidants on the levels of antioxidant enzymes in porcine mesangial cells, suggesting an etiological link between oxidative stress and increased extracellular matrix protein synthesis.
    • (2002) Kidney Int , vol.61 , pp. 599-608
    • Catherwood, M.A.1    Powell, L.A.2    Anderson, P.3
  • 87
    • 18644385337 scopus 로고    scopus 로고
    • Taurine prevents apoptosis induced by high ambient glucose in human tubule renal cells
    • Verzola D, Bertolotto MB, Villaggio B, et al. Taurine prevents apoptosis induced by high ambient glucose in human tubule renal cells. J Investig Med 2002; 50:443-451.
    • (2002) J Investig Med , vol.50 , pp. 443-451
    • Verzola, D.1    Bertolotto, M.B.2    Villaggio, B.3
  • 88
    • 0036252148 scopus 로고    scopus 로고
    • Dietary glutathione protects rats from diabetic nephropathy and neuropathy
    • Ueno Y, Kizaki M, Nakagiri R, et al. Dietary glutathione protects rats from diabetic nephropathy and neuropathy. J Nutr 2002; 132:897-900.
    • (2002) J Nutr , vol.132 , pp. 897-900
    • Ueno, Y.1    Kizaki, M.2    Nakagiri, R.3
  • 89
    • 0036016906 scopus 로고    scopus 로고
    • Oxidative DNA damage and tubulointerstitial injury in diabetic nephropathy
    • Kanauchi M, Nishioka H, Hashimoto T. Oxidative DNA damage and tubulointerstitial injury in diabetic nephropathy. Nephron 2002; 91:327-329. This investigation studied the relationship between oxidative DNA damage and tubulointerstitial injury in type 2 diabetic patients with diabetic nephropathy, suggesting that oxidative stress may contribute to progressive tubulointerstitial injury in diabetic nephropathy.
    • (2002) Nephron , vol.91 , pp. 327-329
    • Kanauchi, M.1    Nishioka, H.2    Hashimoto, T.3
  • 90
    • 0036596185 scopus 로고    scopus 로고
    • Urinary excretion of 8-oxo-7,8-dihydro-2′-deoxyguanosine as a predictor of the development of diabetic nephropathy
    • Hinokio Y, Suzuki S, Hirai M, et al. Urinary excretion of 8-oxo-7,8-dihydro-2′-deoxyguanosine as a predictor of the development of diabetic nephropathy. Diabetologia 2002; 45:877-882. Describes an association between urinary excretion of a product of oxidative DNA damage and development of diabetic nephropathy in Japanese type 2 diabetic patients.
    • (2002) Diabetologia , vol.45 , pp. 877-882
    • Hinokio, Y.1    Suzuki, S.2    Hirai, M.3
  • 91
    • 0037036345 scopus 로고    scopus 로고
    • Advanced glycation end product-induced apoptosis and overexpression of vascular endothelial growth factor and monocyte chemoattractant protein-1 in human-cultured mesangial cells
    • Yamagishi S, Inagaki Y, Okamoto T, et al. Advanced glycation end product-induced apoptosis and overexpression of vascular endothelial growth factor and monocyte chemoattractant protein-1 in human-cultured mesangial cells. J Biol Chem 2002; 277:20309-20315. These authors evaluated the effects of AGEs and N-acetylcysteine, an antioxidant, on human cultured mesangial cell growth and on vascular endothelial growth factor and MCP-1 mesangial cell protein expression.
    • (2002) J Biol Chem , vol.277 , pp. 20309-20315
    • Yamagishi, S.1    Inagaki, Y.2    Okamoto, T.3
  • 92
    • 0036323281 scopus 로고    scopus 로고
    • Effects of mesangium glycation on matrix metalloproteinase activities: Possible role in diabetic nephropathy
    • McLennan SV, Martell SK, Yue DK. Effects of mesangium glycation on matrix metalloproteinase activities: possible role in diabetic nephropathy. Diabetes 2002; 51:2612-2618. This confirms the inhibitory effects of mesangial matrix glycation on extracellular matrix turnover.
    • (2002) Diabetes , vol.51 , pp. 2612-2618
    • McLennan, S.V.1    Martell, S.K.2    Yue, D.K.3
  • 93
    • 0036830463 scopus 로고    scopus 로고
    • Reduction of the accumulation of advanced glycation end products by ACE inhibition in experimental diabetic nephropathy
    • Forbes JM, Cooper ME, Thallas V, et al. Reduction of the accumulation of advanced glycation end products by ACE inhibition in experimental diabetic nephropathy. Diabetes 2002; 51:3274-3282. The authors identify a relationship between the renin-angiotensin system and the accumulation of AGEs in experimental diabetic nephropathy, suggesting that these systems may be linked through oxidative stress.
    • (2002) Diabetes , vol.51 , pp. 3274-3282
    • Forbes, J.M.1    Cooper, M.E.2    Thallas, V.3
  • 94
    • 0036183727 scopus 로고    scopus 로고
    • Pyridoxamine inhibits early renal disease and dyslipidemia in the streptozotocin-diabetic rat
    • Degenhardt TP, Alderson NL, Arrington DD, et al. Pyridoxamine inhibits early renal disease and dyslipidemia in the streptozotocin-diabetic rat. Kidney Int 2002; 61:939-950.
    • (2002) Kidney Int , vol.61 , pp. 939-950
    • Degenhardt, T.P.1    Alderson, N.L.2    Arrington, D.D.3
  • 95
    • 0036892894 scopus 로고    scopus 로고
    • Renal connective tissue growth factor induction in experimental diabetes is prevented by aminoguanidine
    • Twigg SM, Cao Z, SV MC, et al. Renal connective tissue growth factor induction in experimental diabetes is prevented by aminoguanidine. Endocrinology 2002; 143:4907-4915.
    • (2002) Endocrinology , vol.143 , pp. 4907-4915
    • Twigg, S.M.1    Cao, Z.2    Sv, M.C.3
  • 96
    • 0036253802 scopus 로고    scopus 로고
    • Effects of aminoguanidine on lipid and protein oxidation in diabetic rat kidneys
    • Gogasyavuz D, Kucukkaya B, Ersoz HO, et al. Effects of aminoguanidine on lipid and protein oxidation in diabetic rat kidneys. Int J Exp Diabetes Res 2002; 3:145-151.
    • (2002) Int J Exp Diabetes Res , vol.3 , pp. 145-151
    • Gogasyavuz, D.1    Kucukkaya, B.2    Ersoz, H.O.3
  • 97
    • 0036829609 scopus 로고    scopus 로고
    • ALT-946 and aminoguanidine, inhibitors of advanced glycation, improve severe nephropathy in the diabetic transgenic (mREN-2)27 rat
    • Wilkinson-Berka JL, Kelly DJ, Koerner SM, et al. ALT-946 and aminoguanidine, inhibitors of advanced glycation, improve severe nephropathy in the diabetic transgenic (mREN-2)27 rat. Diabetes 2002; 51:3283-3289.
    • (2002) Diabetes , vol.51 , pp. 3283-3289
    • Wilkinson-Berka, J.L.1    Kelly, D.J.2    Koerner, S.M.3
  • 98
    • 0036208878 scopus 로고    scopus 로고
    • Effects of aminoguanidine and tolrestat on the development of ocular and renal structural changes in experimental diabetic rats
    • Azal O, Yonem A, Guler S, et al. Effects of aminoguanidine and tolrestat on the development of ocular and renal structural changes in experimental diabetic rats. Diabetes Obes Metab 2002; 4:75-79.
    • (2002) Diabetes Obes Metab , vol.4 , pp. 75-79
    • Azal, O.1    Yonem, A.2    Guler, S.3
  • 99
    • 0035992568 scopus 로고    scopus 로고
    • The effects of aminoguanidine on renal changes in a baboon model of Type 1 diabetes
    • Birrell AM, Heffernan SJ, Kirwan P, et al. The effects of aminoguanidine on renal changes in a baboon model of Type 1 diabetes. J Diabetes Complications 2002; 16:301-309. This was the first study to investigate the efficacy of aminoguanidine on primary prevention of renal structural lesions in a primate model of type 1 diabetes.
    • (2002) J Diabetes Complications , vol.16 , pp. 301-309
    • Birrell, A.M.1    Heffernan, S.J.2    Kirwan, P.3
  • 100
    • 0036068029 scopus 로고    scopus 로고
    • Normalizing glycated albumin reduces increased urinary collagen IV and prevents renal insufficiency in diabetic db/db mice
    • Cohen MP, Hud E, Shea E, et al. Normalizing glycated albumin reduces increased urinary collagen IV and prevents renal insufficiency in diabetic db/db mice. Metabolism 2002; 51:901-905. This tested if urinary type IV collagen could be a marker of the efficacy of diabetic nephropathy treatment.
    • (2002) Metabolism , vol.51 , pp. 901-905
    • Cohen, M.P.1    Hud, E.2    Shea, E.3
  • 101
    • 0035985243 scopus 로고    scopus 로고
    • Prevention of diabetic nephropathy in mice by a diet low in glycoxidation products
    • Zheng F, He C, Cai W, et al. Prevention of diabetic nephropathy in mice by a diet low in glycoxidation products. Diabetes Metab Res Rev 2002; 18:224-237. These authors demonstrate the contribution of diet-derived AGEs on the development of diabetic glomerular lesions in rodents.
    • (2002) Diabetes Metab Res Rev , vol.18 , pp. 224-237
    • Zheng, F.1    He, C.2    Cai, W.3
  • 102
    • 0037003333 scopus 로고    scopus 로고
    • Amadori-albumin correlates with microvascular complications and precedes nephropathy in type 1 diabetic patients
    • Schalkwijk CG, Chaturvedi N, Twaafhoven H, et al. Amadori-albumin correlates with microvascular complications and precedes nephropathy in type 1 diabetic patients. Eur J Clin Invest 2002; 32:500-506. This assesses the association of Amadori-albumin with early nephropathy and retinopathy in type 1 diabetic patients from the European Community Concerted Action Programme in Diabetes (EURODIAB) Controlled Trial of Lisinopril in Insulin Dependent Diabetes (EUCLID) study.
    • (2002) Eur J Clin Invest , vol.32 , pp. 500-506
    • Schalkwijk, C.G.1    Chaturvedi, N.2    Twaafhoven, H.3
  • 103
    • 0037155923 scopus 로고    scopus 로고
    • Nitric oxide and cGMP-dependent protein kinase regulation of glucose-mediated thrombospondin 1-dependent transforming growth factor-beta activation in mesangial cells
    • Wang S, Shiva S, Poczatek MH, et al. Nitric oxide and cGMP-dependent protein kinase regulation of glucose-mediated thrombospondin 1-dependent transforming growth factor-beta activation in mesangial cells. J Biol Chem 2002; 277:9880-9888. The authors evaluated the role of nitric oxide signaling in the regulation of thrombospondin 1 expression and thrombospondin 1-dependent TGF-β activity in rat mesangial cells exposed to high glucose.
    • (2002) J Biol Chem , vol.277 , pp. 9880-9888
    • Wang, S.1    Shiva, S.2    Poczatek, M.H.3
  • 104
    • 0035995344 scopus 로고    scopus 로고
    • Transforming growth factor-beta-1 latency-associated peptide and soluble betaglycan prevent a glucose-induced increase in fibronectin production in cultured human mesangial cells
    • Nomura K, Tada H, Kuboki K, et al. Transforming growth factor-beta-1 latency-associated peptide and soluble betaglycan prevent a glucose-induced increase in fibronectin production in cultured human mesangial cells. Nephron 2002; 91:606-611. This study investigated the effects of TGF-β latency-associated peptide and betaglycan on TGF-β1 activity, and on the glucose-induced overproduction of fibronectin in cultured human mesangial cells.
    • (2002) Nephron , vol.91 , pp. 606-611
    • Nomura, K.1    Tada, H.2    Kuboki, K.3
  • 105
    • 0037086552 scopus 로고    scopus 로고
    • Decorin suppresses transforming growth factor-beta-induced expression of plasminogen activator inhibitor-1 in human mesangial cells through a mechanism that involves Oa2+-dependent phosphorylation of Smad2 at serine-240
    • Abdel-Wahab N, Wicks SJ, Mason RM, et al. Decorin suppresses transforming growth factor-beta-induced expression of plasminogen activator inhibitor-1 in human mesangial cells through a mechanism that involves Oa2+-dependent phosphorylation of Smad2 at serine-240. Biochem J 2002; 362:643-649.
    • (2002) Biochem J , vol.362 , pp. 643-649
    • Abdel-Wahab, N.1    Wicks, S.J.2    Mason, R.M.3
  • 106
    • 12244298259 scopus 로고    scopus 로고
    • Differential expression of MCP-1 and its receptor CCR2 in glucose primed human mesangial cells
    • Janssen U, Sowa E, Marchand P, et al. Differential expression of MCP-1 and its receptor CCR2 in glucose primed human mesangial cells. Nephron 2002; 92:797-806.
    • (2002) Nephron , vol.92 , pp. 797-806
    • Janssen, U.1    Sowa, E.2    Marchand, P.3
  • 107
    • 0036781581 scopus 로고    scopus 로고
    • Circulating monocyte chemoattractant protein-1 and early development of nephropathy in type 1 diabetes
    • Chiarelli F, Cipollone F, Mohn A, et al. Circulating monocyte chemoattractant protein-1 and early development of nephropathy in type 1 diabetes. Diabetes Care 2002; 25:1829-1834.
    • (2002) Diabetes Care , vol.25 , pp. 1829-1834
    • Chiarelli, F.1    Cipollone, F.2    Mohn, A.3
  • 108
    • 0035988193 scopus 로고    scopus 로고
    • Detection of monocyte-derived microparticles in patients with Type II diabetes mellitus
    • Omoto S, Nomura S, Shouzu A, et al. Detection of monocyte-derived microparticles in patients with Type II diabetes mellitus. Diabetologia 2002; 45:550-555.
    • (2002) Diabetologia , vol.45 , pp. 550-555
    • Omoto, S.1    Nomura, S.2    Shouzu, A.3
  • 109
    • 18244407807 scopus 로고    scopus 로고
    • Urinary levels of monocyte chemoattractant protein-1 (MOP-1) and interleukin-8 (IL-8), and renal injuries in patients with type 2 diabetic nephropathy
    • Tashiro K, Koyanagi I, Saitoh A, et al. Urinary levels of monocyte chemoattractant protein-1 (MOP-1) and interleukin-8 (IL-8), and renal injuries in patients with type 2 diabetic nephropathy. J Clin Lab Anal 2002; 16:1-4. This examines the correlation among urinary levels of MCP-1 and interleukin-8, hyperglycemia, and renal injury, suggesting that measurement of urinary MOP-1 and interleukin-8 may be useful for evaluating the degree of renal injury in patients with type 2 diabetes.
    • (2002) J Clin Lab Anal , vol.16 , pp. 1-4
    • Tashiro, K.1    Koyanagi, I.2    Saitoh, A.3
  • 110
    • 0036039004 scopus 로고    scopus 로고
    • Plasma soluble intercellular adhesion molecule 1 levels are increased in type 2 diabetic patients with nephropathy
    • Guler S, Cakir B, Demirbas B, et al. Plasma soluble intercellular adhesion molecule 1 levels are increased in type 2 diabetic patients with nephropathy. Horm Res 2002; 58:67-70.
    • (2002) Horm Res , vol.58 , pp. 67-70
    • Guler, S.1    Cakir, B.2    Demirbas, B.3
  • 111
    • 0035991936 scopus 로고    scopus 로고
    • Progression of tubulointerstitial injury by osteopontin-induced macrophage recruitment in advanced diabetic nephropathy of transgenic (mRen-2)27 rats
    • Kelly DJ, Wilkinson-Berka JL, Ricardo SD, et al. Progression of tubulointerstitial injury by osteopontin-induced macrophage recruitment in advanced diabetic nephropathy of transgenic (mRen-2)27 rats. Nephrol Dial Transplant 2002; 17:985-991.
    • (2002) Nephrol Dial Transplant , vol.17 , pp. 985-991
    • Kelly, D.J.1    Wilkinson-Berka, J.L.2    Ricardo, S.D.3
  • 113
    • 0036190137 scopus 로고    scopus 로고
    • Effects of aggressive blood pressure control in normotensive type 2 diabetic patients on albuminuria, retinopathy and strokes
    • Schrier RW, Estacio RO, Esler A, et al. Effects of aggressive blood pressure control in normotensive type 2 diabetic patients on albuminuria, retinopathy and strokes. Kidney Int 2002; 61:1086-1097. Prospective, randomized, controlled trial evaluating the effects of five-year intensive versus moderate diastolic blood pressure control on diabetic vascular complications in 'normotensive' type 2 diabetic patients.
    • (2002) Kidney Int , vol.61 , pp. 1086-1097
    • Schrier, R.W.1    Estacio, R.O.2    Esler, A.3
  • 114
    • 0035922444 scopus 로고    scopus 로고
    • The effect of irbesartan on the development of diabetic nephropathy in patients with type 2 diabetes
    • Parving HH, Lehnert H, Brochner-Mortensen J, et al. The effect of irbesartan on the development of diabetic nephropathy in patients with type 2 diabetes. N Engl J Med 2001; 345:870-878.
    • (2001) N Engl J Med , vol.345 , pp. 870-878
    • Parving, H.H.1    Lehnert, H.2    Brochner-Mortensen, J.3
  • 115
    • 0037031270 scopus 로고    scopus 로고
    • Microalbuminuria reduction with valsartan in patients with type 2 diabetes mellitus: A blood pressure-independent effect
    • Viberti G, Wheeldon NM. Microalbuminuria reduction with valsartan in patients with type 2 diabetes mellitus: a blood pressure-independent effect. Circulation 2002; 106:672-678. This evaluates the effects of valsartan, an angiotensin II type 1 receptor-blocker, on urinary albumin excretion rate of 332 microalbuminuric type 2 diabetic patients included in the MicroAlbuminuria Reduction with VALsartan (MARVAL) study.
    • (2002) Circulation , vol.106 , pp. 672-678
    • Viberti, G.1    Wheeldon, N.M.2
  • 116
    • 0036067729 scopus 로고    scopus 로고
    • Beraprost sodium, prostacyclin analogue, attenuates glomerular hyperfiltration and glomerular macrophage infiltration by modulating ecNOS expression in diabetic rats
    • Yamashita T, Shikata K, Matsuda M, et al. Beraprost sodium, prostacyclin analogue, attenuates glomerular hyperfiltration and glomerular macrophage infiltration by modulating ecNOS expression in diabetic rats. Diabetes Res Clin Pract 2002; 57:149-161.
    • (2002) Diabetes Res Clin Pract , vol.57 , pp. 149-161
    • Yamashita, T.1    Shikata, K.2    Matsuda, M.3
  • 117
    • 0036969949 scopus 로고    scopus 로고
    • Effect of long-term administration of prostaglandin I(2) in incipient diabetic nephropathy
    • Owada A, Suda S, Hata T. Effect of long-term administration of prostaglandin I(2) in incipient diabetic nephropathy. Nephron 2002; 92:788-796.
    • (2002) Nephron , vol.92 , pp. 788-796
    • Owada, A.1    Suda, S.2    Hata, T.3
  • 118
    • 0036288407 scopus 로고    scopus 로고
    • Inhibitory effect of ibudilast on urinary albumin excretion in type 2 diabetes mellitus with microalbuminuria
    • Hoshino T, Ikeda T. Inhibitory effect of ibudilast on urinary albumin excretion in type 2 diabetes mellitus with microalbuminuria. Nephron 2002; 90:154-157.
    • (2002) Nephron , vol.90 , pp. 154-157
    • Hoshino, T.1    Ikeda, T.2
  • 119
    • 0036014944 scopus 로고    scopus 로고
    • Oral sulodexide reduces albuminuria in microalbuminuric and macroalbuminuric type 1 and type 2 diabetic patients: The Di.N.A.S. randomized trial
    • Gambaro G, Kinalska I, Oksa A, et al. Oral sulodexide reduces albuminuria in microalbuminuric and macroalbuminuric type 1 and type 2 diabetic patients: the Di.N.A.S. randomized trial. J Am Soc Nephrol 2002; 13:1615-1625. The authors describe the results of a randomized, double-blind, placebo-controlled, multicenter, dose-range finding trial evaluating the extent and duration of the reduction in albuminuria by oral sulodexide, a glycosaminoglycan, in microalbuminuric and proteinuric type 1 and type 2 diabetic patients.
    • (2002) J Am Soc Nephrol , vol.13 , pp. 1615-1625
    • Gambaro, G.1    Kinalska, I.2    Oksa, A.3
  • 120
    • 0036837092 scopus 로고    scopus 로고
    • Sarpogrelate hydrochloride, a serotonin2A receptor antagonist, reduces albuminuria in diabetic patients with early-stage diabetic nephropathy
    • Takahashi T, Yano M, Minami J, et al. Sarpogrelate hydrochloride, a serotonin2A receptor antagonist, reduces albuminuria in diabetic patients with early-stage diabetic nephropathy. Diabetes Res Clin Pract 2002; 58:123-129.
    • (2002) Diabetes Res Clin Pract , vol.58 , pp. 123-129
    • Takahashi, T.1    Yano, M.2    Minami, J.3
  • 121
    • 0036167784 scopus 로고    scopus 로고
    • A blood pressure cut-off level identified for renal failure, but not for macrovascular complications in type 2 diabetes: A 10-year observation study
    • Torffvit O, Agardh CD. A blood pressure cut-off level identified for renal failure, but not for macrovascular complications in type 2 diabetes: a 10-year observation study. Horm Metab Res 2002; 34:32-35. This longitudinal study aimed to identify the existance of a cut-off blood pressure level for major complications (myocardial infarction, stroke, renal failure or death) in patients with type 2 diabetes.
    • (2002) Horm Metab Res , vol.34 , pp. 32-35
    • Torffvit, O.1    Agardh, C.D.2
  • 122
    • 0035922447 scopus 로고    scopus 로고
    • Renoprotective effect of the angiotensin-receptor antagonist irbesartan in patients with nephropathy due to type 2 diabetes
    • Lewis EJ, Hunsicker LG, Clarke WR, et al. Renoprotective effect of the angiotensin-receptor antagonist irbesartan in patients with nephropathy due to type 2 diabetes. N Engl J Med 2001; 345:851-860.
    • (2001) N Engl J Med , vol.345 , pp. 851-860
    • Lewis, E.J.1    Hunsicker, L.G.2    Clarke, W.R.3
  • 123
    • 0035922441 scopus 로고    scopus 로고
    • Effects of losartan on renal and cardiovascular outcomes in patients with type 2 diabetes and nephropathy
    • Brenner BM, Cooper ME, de Zeeuw D, et al. Effects of losartan on renal and cardiovascular outcomes in patients with type 2 diabetes and nephropathy. N Engl J Med 2001; 345:861-869.
    • (2001) N Engl J Med , vol.345 , pp. 861-869
    • Brenner, B.M.1    Cooper, M.E.2    De Zeeuw, D.3
  • 124
    • 0035991954 scopus 로고    scopus 로고
    • Dual blockade of the renin-angiotensin system in type 1 patients with diabetic nephropathy
    • Jacobsen P, Andersen S, Rossing K, et al. Dual blockade of the renin-angiotensin system in type 1 patients with diabetic nephropathy. Nephrol Dial Transplant 2002; 17:1019-1024. This evaluated the effects of the association of angiotensin II type 1 receptor-blocker with angiotensin converting enzyme inhibitor in proteinuric patients with type 1 diabetes.
    • (2002) Nephrol Dial Transplant , vol.17 , pp. 1019-1024
    • Jacobsen, P.1    Andersen, S.2    Rossing, K.3
  • 125
    • 0036369626 scopus 로고    scopus 로고
    • Dual blockade of the renin-angiotensin system in diabetic nephropathy: A randomized double-blind crossover study
    • Rossing K, Christensen PK, Jensen BR, et al. Dual blockade of the renin-angiotensin system in diabetic nephropathy: a randomized double-blind crossover study. Diabetes Care 2002; 25:95-100. These authors evaluated the effects of the association of angiotensin II type 1 receptor-blocker with ACE inhibitor in proteinuric patients with type 2 diabetes.
    • (2002) Diabetes Care , vol.25 , pp. 95-100
    • Rossing, K.1    Christensen, P.K.2    Jensen, B.R.3
  • 126
    • 0036191924 scopus 로고    scopus 로고
    • Add-on angiotensin II receptor blockade lowers urinary transforming growth factor-beta levels
    • Agarwal R, Siva S, Dunn SR, et al. Add-on angiotensin II receptor blockade lowers urinary transforming growth factor-beta levels. Am J Kidney Dis 2002; 39:486-492. The study evaluated the changes on urinary TGF-β1 levels induced by an angiotensin II type 1 receptor-blocker, added to a background of chronic maximal angiotensin converting enzyme inhibitor therapy, in patients with proteinuria.
    • (2002) Am J Kidney Dis , vol.39 , pp. 486-492
    • Agarwal, R.1    Siva, S.2    Dunn, S.R.3
  • 127
    • 0036311086 scopus 로고    scopus 로고
    • Effect of dietary protein restriction on prognosis in patients with diabetic nephropathy
    • Hansen HP, Tauber-Lassen E, Jensen BR, et al. Effect of dietary protein restriction on prognosis in patients with diabetic nephropathy. Kidney Int 2002; 62:220-228.
    • (2002) Kidney Int , vol.62 , pp. 220-228
    • Hansen, H.P.1    Tauber-Lassen, E.2    Jensen, B.R.3
  • 128
    • 0036233173 scopus 로고    scopus 로고
    • A comparative randomized and placebo-controlled short-term trial of aspirin and dipyridamole for overt type-2 diabetic nephropathy
    • Khajehdehi P, Roozbeh J, Mostafavi H. A comparative randomized and placebo-controlled short-term trial of aspirin and dipyridamole for overt type-2 diabetic nephropathy. Stand J Urol Nephrol 2002; 36:145-148.
    • (2002) Stand J Urol Nephrol , vol.36 , pp. 145-148
    • Khajehdehi, P.1    Roozbeh, J.2    Mostafavi, H.3
  • 129
    • 0036362822 scopus 로고    scopus 로고
    • Tranilast slows the progression of advanced diabetic nephropathy
    • Soma J, Sugawara T, Huang YD, et al. Tranilast slows the progression of advanced diabetic nephropathy. Nephron 2002; 92:693-698.
    • (2002) Nephron , vol.92 , pp. 693-698
    • Soma, J.1    Sugawara, T.2    Huang, Y.D.3
  • 130
    • 0037092913 scopus 로고    scopus 로고
    • Cost-effectiveness of intensive glycemic control, intensified hypertension control, and serum cholesterol level reduction for type 2 diabetes
    • The CDC Diabetes Cost-effectiveness Group. Cost-effectiveness of intensive glycemic control, intensified hypertension control, and serum cholesterol level reduction for type 2 diabetes. JAMA 2002; 287:2542-2551. This estimates the cost-effectiveness of intensive glycemic control, intensified hypertension control, and reduction in serum cholesterol levels for patients with type 2 diabetes based on the results of the United Kingdom Prospective Diabetes Study and other studies.
    • (2002) JAMA , vol.287 , pp. 2542-2551
  • 131
    • 0037061867 scopus 로고    scopus 로고
    • Clinical practice. Nephropathy in patients with type 2 diabetes
    • Remuzzi G, Schieppati A, Ruggenenti P. Clinical practice. Nephropathy in patients with type 2 diabetes. N Engl J Med 2002; 346:1145-1151.
    • (2002) N Engl J Med , vol.346 , pp. 1145-1151
    • Remuzzi, G.1    Schieppati, A.2    Ruggenenti, P.3


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.